US Stock MarketDetailed Quotes

REGN Regeneron Pharmaceuticals

Watchlist
  • 754.870
  • +1.840+0.24%
Close Nov 27 16:00 ET
82.95BMarket Cap18.67P/E (TTM)

Regeneron Pharmaceuticals Key Stats

Regeneron Pharmaceuticals Q3 2024 Earnings Date

Currency:USDOct 31, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
3.67B
3.72B
+53.88M
Beat Est.
+9.04%
+10.65%
+1.47%
EPS
9.58
11.54
+1.96
Beat Est.
+7.81%
+29.81%
+20.41%
Buy

Nov 14, 2024

Regeneron Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.630B--
--2024/Q4-- / 3.753B--
Oct 31, 20242024/Q33.721B / 3.667B--
Aug 1, 20242024/Q23.547B / 3.387B--
May 2, 20242024/Q13.145B / 3.221B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.630B--
--2024/Q4-- / 3.753B--
Oct 31, 20242024/Q33.721B / 3.667B--
Aug 1, 20242024/Q23.547B / 3.387B--
May 2, 20242024/Q13.145B / 3.221B--

Unlock Free Earnings Estimates

Regeneron Pharmaceuticals Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Nov 14, 2024

Buy

  • Buy

    75.00%
  • Hold

    20.83%
  • Sell

    4.17%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data